Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2477 |  ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -5.71% | -25.93% | -38.11% | 946.91 M USD | ||
| 2490 |  ANNX Annexon, Inc. - common stock | 4.84 USD | -4.54% | -4.91% | -8.68% | +110.43% | 917.56 M USD | ||
| 2508 |  DSGN Design Therapeutics, Inc. - Common Stock | 15.01 USD | +0.13% | +1.90% | +16.72% | +186.45% | 939.35 M USD | ||
| 2510 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.40 USD | -2.71% | -2.26% | -13.19% | +26.98% | 909.98 M USD | ||
| 2531 |  IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -0.43% | +4.50% | -2.73% | 896.62 M USD | ||
| 2547 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2558 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.64 USD | -7.52% | +9.25% | +43.25% | +29.56% | 808.78 M USD | ||
| 2577 |  DBVT DBV Technologies S.A. - American Depositary Shares | 14.01 USD | -3.71% | -4.04% | +1.89% | +42.81% | 829.56 M USD | ||
| 2579 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.05 USD | -1.83% | +5.38% | +20.78% | +49.52% | 841.53 M USD | ||
| 2602 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.51 USD | -2.21% | -3.92% | -11.12% | -19.28% | 807.63 M USD | ||
| 2606 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.72 USD | -3.38% | +4.61% | +24.92% | +144.30% | 794.41 M USD | ||
| 2621 |  AURA Aura Biosciences, Inc. - Common Stock | 7.61 USD | -2.44% | -1.04% | +7.18% | +16.36% | 789.19 M USD | ||
| 2652 |  NGNE Neurogene Inc. - Common Stock | 38.09 USD | -1.40% | +5.10% | +8.83% | +29.47% | 762.23 M USD | ||
| 2656 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.86 USD | -0.72% | +3.63% | +14.14% | -16.95% | 764.96 M USD | ||
| 2657 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.47 USD | -0.38% | +23.27% | +21.17% | +240.64% | 764.69 M USD | ||
| 2667 |  STTK Shattuck Labs, Inc. - Common Stock | 7.73 USD | +2.66% | +5.03% | +4.88% | +731.18% | 775.81 M USD | ||
| 2680 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.05 USD | -4.20% | +4.22% | +18.08% | +110.20% | 704.75 M USD | ||
| 2685 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.08 USD | 0.00% | +0.44% | +0.89% | +0.22% | 727.98 M USD | ||
| 2688 |  MNPR Monopar Therapeutics Inc. - Common Stock | 106.13 USD | -1.48% | -8.31% | -3.77% | +94.31% | 712.36 M USD | ||
| 2691 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.02 USD | -3.35% | -1.46% | +12.22% | +66.94% | 697.89 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |